Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Metabolic Genetics

Building Your Team and Long-Term Monitoring

At a Glance

People with methylmalonic acidemia with homocystinuria need lifelong, individualized care coordinated by a metabolic genetics team, with regular checks of metabolism, kidneys, eyes, heart, and cognitive health. Planning for adult care and pregnancy should begin early with specialists.

Living with Methylmalonic Acidemia with Homocystinuria (MMA-HCU) is a lifelong journey that requires a dedicated “pit crew” of experts. Because the cblC defect can impact the eyes, kidneys, heart, and brain, care must be multidisciplinary—meaning many different specialists working together to keep you or your child healthy and stable [1][2].

Building Your Multidisciplinary Team

Your care is usually anchored by a Metabolic Geneticist (or Biochemical Geneticist), who oversees the diagnosis, adjusts medications like hydroxocobalamin and betaine, and coordinates the rest of the team [1]. Other essential or optional members include:

  • Metabolic Dietitian: Crucial for ensuring you get enough natural protein and methionine to support growth and brain health [3].
  • Ophthalmologist: Ideally one with retinal expertise, to monitor for maculopathy using specialized imaging like OCT and ERG [4][5].
  • Nephrologist: To monitor kidney health and watch for signs of Thrombotic Microangiopathy (TMA) [6].
  • Cardiologist: To perform regular echocardiograms (heart ultrasounds) to check for pulmonary hypertension [7].
  • Neurologist, Neuropsychologist, & Psychiatrist: To track developmental progress, manage any seizures, and support cognitive health through school and work [8][9].
  • Support Services: Social work, psychology, rehabilitation, and school/work support can be invaluable, including creating an education plan for teachers, coaches, and employers.

Your Routine Monitoring Framework

While every patient is unique, standard care involves regular “surveillance” to catch any changes before they become emergencies. Note that the frequency and applicability of these tests vary by age, onset, symptoms, prior complications, and local expertise. You should expect a tailored selection of the following tests:

Category Typical Tests What They Check
Metabolic tHcy, MMA, Methionine How well your medications are working [1].
Renal/Blood CBC, Creatinine, Urinalysis Kidney function and signs of blood vessel stress [6].
Vision Dilated Exam, OCT, ERG The health of the retina and optic nerve [10].
Cardiac Echocardiogram, BNP Pressure in the lungs and heart function [7][11].
Neuro Neuropsychological Testing Cognitive strengths and support needs [8].

(When TMA is a concern, additional blood-pressure, urine-protein, and hemolysis evaluation is used.)

Navigating Life Transitions

As children with MMA-HCU grow into adults, their care needs to shift. This transition is not a single event but a process that should begin in the early teen years [12]. The goal is to gradually move the responsibility for daily injections, diet management, and appointment scheduling from the parent to the young adult [13]. A successful transition involves finding adult metabolic specialists who understand the unique needs of the cblC community [12].

Genetics, Family Planning, and Pregnancy

MMA-HCU is an autosomal recessive condition, meaning both parents typically carry one copy of the mutated gene. Reproductive counseling is recommended for all affected individuals, including partner carrier testing and discussion of the recurrence risk.

For women with MMA-HCU, starting a family is a significant milestone. Successful, full-term pregnancies are reported and possible with careful planning [14][15].

The key is rigorous metabolic control and preconception genetic counseling. Women often need adjusted doses of hydroxocobalamin and betaine to keep homocysteine levels low during pregnancy [16]. Because high homocysteine increases the risk of blood clots, doctors may also consider anticoagulants (like heparin) based on prior thrombosis, current risk factors, and specialist assessment by maternal-fetal medicine and hematology. Anticoagulation is not routine for every person and can cause harm, so explicitly do not start it without the treating team [15][17]. The period immediately after birth (postpartum) is also a high-risk time for metabolic shifts requiring close monitoring.

Looking Forward

A diagnosis of MMA-HCU brings significant demands, but it does not define your future. With a proactive care team, consistent treatment, and regular monitoring, patients are attending school, pursuing careers, and raising families [9][15]. By staying informed and engaged with your “pit crew,” you can manage the complexities of the cblC defect and focus on living a full and vibrant life.

Common questions in this guide

Who usually coordinates care for someone with MMA-HCU?
A metabolic geneticist or biochemical geneticist often serves as the main care coordinator. This specialist may adjust treatments such as hydroxocobalamin and betaine and bring together dietitians, eye, kidney, heart, neurologic, mental health, and other support services.
What tests are commonly used to monitor MMA-HCU over time?
Monitoring may include total homocysteine, methylmalonic acid, and methionine testing; blood counts, creatinine, and urine tests; retinal scans such as OCT and ERG; echocardiograms or BNP; and neuropsychological testing. The schedule depends on age, onset type, symptoms, previous complications, and local expertise.
When should a child with MMA-HCU start preparing for adult care?
Transition planning should begin in the early teen years rather than at a single handoff. The young person can gradually take responsibility for injections, diet, records, and appointments while the family identifies an adult metabolic specialist.
Can a person with MMA-HCU have a successful pregnancy?
Successful full-term pregnancies are possible, but pregnancy should be planned with metabolic genetics, maternal-fetal medicine, and other appropriate specialists. Treatment may need adjustment to maintain metabolic control, and the postpartum period requires close monitoring; anticoagulants are not routine and should never be started without the treating team.
What genetic counseling is recommended for MMA-HCU and family planning?
Because MMA-HCU is usually autosomal recessive, both parents typically carry one altered gene copy. Affected people can discuss partner carrier testing, recurrence risk, and testing for other family members with a genetics professional.
How can school or work support be included in MMA-HCU care?
Social work, psychology, rehabilitation, and school or workplace support can be part of the care team. An individualized education or emergency plan can help teachers, coaches, and employers understand daily needs and what to do if a health problem occurs.

Get notified when new evidence is published on Methylmalonic acidemia with homocystinuria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders.

    Olivieri G, Bordugo A, Burnyte B, et al.

    Journal of inherited metabolic disease 2026; (49(4)):e70177 doi:10.1002/jimd.70177.

    PMID: 42231716
  2. 2

    Hemolytic Uremic Syndrome Due to Methylmalonic Acidemia and Homocystinuria in an Infant: A Case Report and Literature Review.

    Karava V, Kondou A, Dotis J, et al.

    Children (Basel, Switzerland) 2021; (8(2)) doi:10.3390/children8020112.

    PMID: 33562640
  3. 3

    Efficacy of early treatment in patients with cobalamin C disease identified by newborn screening: a 16-year experience.

    Ahrens-Nicklas RC, Whitaker AM, Kaplan P, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(8)):926-935 doi:10.1038/gim.2016.214.

    PMID: 28151490
  4. 4

    Ocular disease in the cobalamin C defect: a review of the literature and a suggested framework for clinical surveillance.

    Weisfeld-Adams JD, McCourt EA, Diaz GA, Oliver SC

    Molecular genetics and metabolism 2015; (114(4)):537-46.

    PMID: 25742969
  5. 5

    Retinal Changes in Early-Onset cblC Methylmalonic Acidemia Identified Through Expanded Newborn Screening: Highlights from a Case Study and Literature Review.

    Michieletto P, Baldo F, Madonia M, et al.

    Genes 2025; (16(6)) doi:10.3390/genes16060635.

    PMID: 40565527
  6. 6

    Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity.

    Beck BB, van Spronsen F, Diepstra A, et al.

    Pediatric nephrology (Berlin, Germany) 2017; (32(5)):733-741 doi:10.1007/s00467-016-3399-0.

    PMID: 27289364
  7. 7

    Long-term outcome of CblC deficiency complicated with pulmonary hypertension.

    Ding S, Deng Y, Hao L, et al.

    Orphanet journal of rare diseases 2025; (20(1)):276 doi:10.1186/s13023-025-03839-5.

    PMID: 40468431
  8. 8

    A Highly Diverse Portrait: Heterogeneity of Neuropsychological Profiles in cblC Defect.

    Bellerose J, Neugnot-Cerioli M, Bédard K, et al.

    JIMD reports 2016; (29()):19-32 doi:10.1007/8904_2015_517.

    PMID: 26608391
  9. 9

    Late-onset methylmalonic acidemia and homocysteinemia (cblC disease): systematic review.

    Arhip L, Brox-Torrecilla N, Romero I, et al.

    Orphanet journal of rare diseases 2024; (19(1)):20 doi:10.1186/s13023-024-03021-3.

    PMID: 38245797
  10. 10

    Ophthalmic Manifestations and Long-Term Visual Outcomes in Patients with Cobalamin C Deficiency.

    Brooks BP, Thompson AH, Sloan JL, et al.

    Ophthalmology 2016; (123(3)):571-82.

    PMID: 26825575
  11. 11

    [Pulmonary arterial hypertension as leading manifestation of methylmalonic aciduria: clinical characteristics and gene testing in 15 cases].

    Liu XQ, Yan H, Qiu JX, et al.

    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2017; (49(5)):768-777.

    PMID: 29045954
  12. 12

    Transition from pediatric to adult care in adolescents with hereditary metabolic diseases: Specific guidelines from the French network for rare inherited metabolic diseases (G2M).

    Chabrol B, Jacquin P, Francois L, et al.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2018; doi:10.1016/j.arcped.2018.05.009.

    PMID: 29914755
  13. 13

    Health care transition from pediatric to adult care: an evidence-based guideline.

    Pape L, Ernst G

    European journal of pediatrics 2022; (181(5)):1951-1958 doi:10.1007/s00431-022-04385-z.

    PMID: 35084548
  14. 14

    Case report: An asymptomatic mother with an inborn error of cobalamin metabolism (cblC) detected through high homocysteine levels during prenatal diagnosis.

    Liu YP, He RX, Chen ZH, et al.

    Frontiers in nutrition 2023; (10()):1124387 doi:10.3389/fnut.2023.1124387.

    PMID: 37252234
  15. 15

    Prospective evaluation of pregnancy outcome in an Italian woman with late-onset combined homocystinuria and methylmalonic aciduria.

    Grandone E, Martinelli P, Villani M, et al.

    BMC pregnancy and childbirth 2019; (19(1)):318 doi:10.1186/s12884-019-2474-5.

    PMID: 31470807
  16. 16

    Successful intrauterine treatment of a patient with cobalamin C defect.

    Trefz FK, Scheible D, Frauendienst-Egger G, et al.

    Molecular genetics and metabolism reports 2016; (6()):55-9 doi:10.1016/j.ymgmr.2016.01.005.

    PMID: 27014578
  17. 17

    Encephalitis-like presentation of methylmalonic acidemia with homocystinuria in a postpartum woman: a case report.

    Wang Q, Ji Z, Wang Y, Qi Z

    Frontiers in psychiatry 2026; (17()):1734901 doi:10.3389/fpsyt.2026.1734901.

    PMID: 41890422

This page is for informational purposes only and does not constitute medical advice or replace your metabolic care team. Do not change medicines or start anticoagulants; pregnancy and monitoring decisions should be made with your treating specialists.